10x Genomics, Inc.
10x Genomics, Inc. (TXG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TXG · as of Jun 9, 2026
Key Statistics
Explore 10x Genomics, Inc. Data
txg stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 22 · Buy rate: 45.5%
The TXG analyst consensus is Hold, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $22.43, representing -23.13% downside from the current price of $29.18.
Competitors & Peers
txg competitorsTXG
CERT
GRDN
JANX
NUVB
OMCLStock Performance
Full HistoryAbout 10x Genomics, Inc.
10x Genomics, Inc. Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializ…
what is 10x genomics, inc. · txg stock overview · 10x genomics, inc. company profile · who is 10x genomics, inc. ceo · txg NASDAQ · 10x genomics, inc. headquarters · 10x genomics, inc. business segments
About Stock Overview & Key Data
10x Genomics, Inc. (TXG) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Sep 12, 2019. As of the latest trading session, TXG stock price is $29.18, with a market capitalization of $3.7B. The stock has returned +193.56% over the past 12 months and +81.61% year-to-date.
According to 22 Wall Street analysts, the consensus rating for 10x Genomics, Inc. stock is Hold, with an average 12-month price target of $22.43. In fiscal year 2025, 10x Genomics, Inc. reported revenue of $642.8M and net income of -$43.5M. For detailed data — including 10x Genomics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, 10x Genomics, Inc. (TXG) stock price is $29.18. The stock is traded on NASDAQ under the ticker symbol TXG. The 52-week range is $9.30 – $35.65.